Legacy Wealth Managment »

Fate Therapeutics shares owned by Legacy Wealth Managment

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Legacy Wealth Managment from 13F filings

Historical chart of Legacy Wealth Managment investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Legacy Wealth Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Legacy Wealth Managment

Quarter filed Position value Share count Share price at filing
2024-09-30 $249 115 2.17

More positions owned by Legacy Wealth Managment

NeoVo (NEOV)
Proshares Tr Bitcoin Etf (BITO)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Simplify Exchange Traded Fun Volatility Prem (SVOL)
Proshares Tr Ether Etf (EETH)
Devon Energy Corporation (DVN)
Fs Kkr Capital Corp (FSK)
Spdr S&p 500 Etf Tr Put Put Option (Principal) (SPY)
Ishares Tr Blackrock Ultra (ICSH)
Invesco Actively Managed Exc Ultra Shrt Dur (GSY)
Uscf Etf Tr Gold Strategy (USG)
J P Morgan Exchange Traded F Income Etf (JPIE)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)

View all positions for Legacy Wealth Managment

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Deep Track Capital
Bellevue Group
Citadel Advisors
Deerfield Management Company
Johnson & Johnson
Baker Bros. Advisors
EcoR1 Capital
Dimensional Fund Advisors
Morgan Stanley
Goldman Sachs Group
State Street Corporation
Geode Capital Management

View all funds holding Fate Therapeutics